Two significant programs that invested in research on diabetes, dementia, obesity and kidney disease have ended since the start of the Trump administration. www.nytimes.com
Two significant programs that invested in research on diabetes, dementia, obesity and kidney disease have ended since the start of the Trump administration.
www.nytimes.com